| Literature DB >> 15704860 |
Marion Kanwischer1, Seok-Yong Kim, Jung Sun Kim, Shengjie Bian, Kyoung Ae Kwon, Dae-Duk Kim.
Abstract
Glucosamine sulfate (GS) is known to stop the degenerative process of osteoarthritis. Because most of the GS formulation on the market is in the oral form, an alternative formulation such as a transdermal delivery system (TDS) is necessary in order to increase patient compliance. As the initial step to develop a TDS of GS, the physicochemical stability and permeation study in rat skin were examined. Evaluation of the stability of GS at different pHs showed the compound to be most stable at pH 5.0. The degradation rate constant at 25 degrees C was estimated to be 5.93 x 10(-6) hr(-1) (t90 approximately 2.03 years) in a pH 5 buffer solution. Due to its hydrophilic characteristic, low skin permeability was expected of GS. However, the skin permeation rate was determined to be 13.27 microg/cm2/hr at 5% concentration. Results of this study suggest the possibility of developing GS into a transdermal delivery system.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15704860 DOI: 10.1081/ddc-44181
Source DB: PubMed Journal: Drug Dev Ind Pharm ISSN: 0363-9045 Impact factor: 3.225